FTO is upregulated and exhibits a tumor-promoting role in the majority of cancer types [10], including acute myeloid leukemia (AML) [11], breast cancer [12, 13], liver cancer [14], gastric cancer [15] and colorectal cancer [16]. This evidence concerns the gene FTO and neoplasm.